Sinusitis in patients undergoing allogeneic bone marrow transplantation – a review  by Drozd-Sokolowska, Joanna Ewa et al.
ARTICLE IN PRESS+Model
Braz J Otorhinolaryngol. 2016;xxx(xx):xxx--xxx
www.bjorl.org
Brazilian Journal of
OTORHINOLARYNGOLOGY
REVIEW ARTICLE
Sinusitis  in patients  undergoing  allogeneic  bone
marrow transplantation  -- a review
Joanna Ewa Drozd-Sokolowskaa, Jacek Sokolowskib,∗, Wieslaw Wiktor-Jedrzejczaka,
Kazimierz  Niemczykb
a The  Medical  University  of  Warsaw,  Oncology  and  Internal  Diseases,  Department  of  Hematology,  Warsaw,  Poland
b The  Medical  University  of  Warsaw,  Department  of  Otorhinolaryngology,  Warsaw,  Poland
Received 15  September  2015;  accepted  19  February  2016
KEYWORDS
Sinusitis;
Sinusitis  treatment;
Hematopoietic  stem
cell  transplantation;
Bone  marrow
transplantation
Abstract
Introduction:  Sinusitis  is  a  common  morbidity  in  general  population,  however  little  is
known about  its  occurrence  in  severely  immunocompromised  patients  undergoing  allogeneic
hematopoietic  stem  cell  transplantation.
Objective:  The  aim  of  the  study  was  to  analyze  the  literature  concerning  sinusitis  in  patients
undergoing  allogeneic  bone  marrow  transplantation.
Methods:  An  electronic  database  search  was  performed  with  the  objective  of  identifying  all
original trials  examining  sinusitis  in  allogeneic  hematopoietic  stem  cell  transplant  recipients.
The search  was  limited  to  English-language  publications.
Results:  Twenty  ﬁve  studies,  published  between  1985  and  2015  were  identiﬁed,  none  of  them
being a  randomized  clinical  trial.  They  reported  on  31--955  patients,  discussing  different  issues
i.e. value  of  pretransplant  sinonasal  evaluation  and  its  impact  on  post-transplant  morbidity  and
mortality, treatment,  risk  factors  analysis.
Conclusion:  Results  from  analyzed  studies  yielded  inconsistent  results.  Nevertheless,  some
recommendations  for  good  practice  could  be  made.  First,  it  seems  advisable  to  screen  all
patients undergoing  allogeneic  hematopoietic  stem  cell  transplantation  with  Computed  Tomo-
graphy (CT)  prior  to  procedure.  Second,  patients  with  symptoms  of  sinusitis  should  be  treated
before hematopoietic  stem  cell  transplantation  (HSCT),  preferably  with  conservative  medical
approach. Third,  patients  who  have  undergone  hematopoietic  stem  cell  transplantation  should
be monitored  closely  for  sinusitis,  especially  in  the  early  period  after  transplantation.
© 2016  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Published
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Sinusite  em  pacientes  submetidos  a  transplante  alogênico  de  medula  óssea  --  uma
revisão
Resumo
Introduc¸ão:  A  sinusite  é  uma  morbidade  comum  na  populac¸ão  em  geral,  porém  pouco  se  sabe
sobre a  sua  ocorrência  em  pacientes  gravemente  imunocomprometidos  submetidos  a  trans-
plante alogênico  de  células-tronco  hematopoiéticas.
Objetivo:  O  objetivo  do  estudo  foi  analisar  a  literatura  sobre  sinusite  em  pacientes  submetidos
a transplante  alogênico  de  medula  óssea.
Método:  Uma  busca  na  base  de  dados  eletrônica  foi  realizada  com  o  objetivo  de  identiﬁcar
todos os  ensaios  originais  que  examinam  sinusite  em  receptores  de  transplante  alogênico  de
células-tronco  hematopoiéticas.  A  busca  foi  limitada  a  publicac¸ões  em  língua  inglesa.
Resultados:  Foram  identiﬁcados  vinte  e  cinco  estudos,  publicados  entre  1985  e  2015,  sendo
que nenhum  deles  era  um  ensaio  clínico  randomizado.  Eles  relataram  sobre  31-955  pacientes,
discutindo diferentes  questões  de  valor,  ou  seja,  valor  da  avaliac¸ão  sinonasal  pré-transplante
e seu  impacto  na  morbidade  e  mortalidade  pós-transplante,  tratamento,  análise  de  fatores  de
risco.
Conclusão:  Os  resultados  dos  estudos  analisados  produziram  resultados  inconsistentes.  No
entanto, algumas  recomendac¸ões  para  boas  práticas  poderiam  ser  feitas.  Em  primeiro  lugar,
parece aconselhável  avaliar  todos  os  pacientes  submetidos  a  transplante  alogênico  de  células-
tronco hematopoiéticas  com  tomograﬁa  computadorizada  (TC)  antes  do  procedimento.  Em
segundo lugar,  os  pacientes  com  sintomas  de  sinusite  devem  ser  tratados  antes  de  Transplante
de Células  Tronco  Hematopoiéticas  (TCTH),  de  preferência  com  a  abordagem  clínica  conser-
vadora. Em  terceiro  lugar,  os  pacientes  que  se  submeteram  a  TCTH  devem  ser  cuidadosamente
monitorizados  para  sinusite,  especialmente  no  período  inicial  após  o  transplante.
© 2016  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Publicado
por Elsevier  Editora  Ltda.  Este e´  um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY  (http://
creativecommons.org/licenses/by/4.0/).
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some  analyzed  solely  patients  who  developed  sinusitisntroduction
one  marrow  transplantation  is  used  to  treat  a  variety  of
ematological  disorders  either  neoplastic  or  non-neoplastic.
oth,  these  primary  disorders  and  aforementioned  treat-
ent  induce  profound  immunosuppression  affecting  non-
peciﬁc  and  speciﬁc  immunity  including  both  humoral  and
ellular  effectors  mechanisms.  As  the  consequence,  there  is
n  increased  incidence  of  different  types  of  infections  in  the
ost-transplant  period,  which  have  been  extensively  stud-
ed.  However,  paranasal  sinusitis,  which  is  one  of  the  most
ommon  infections  in  general  population,  has  been  evalu-
ted  only  in  a  few  trials.  Similarly  only  incidental  reports
oncern  invasive  fungal  sinusitis,  which  is  typically  associ-
ted  with  bone  destruction  in  the  affected  area.  According
o  a  few  published  papers  sinusitis  affects  approximately
--44%  of  all  patients  in  the  post-transplantation  period,
ostly  during  the  early  post-transplant  phase.1--6 There  are
o  well  deﬁned  risk  factors  of  acute  sinusitis  and  ﬂare  ups
f  chronic  sinusitis  in  hematopoietic  stem  cell  transplant
ecipients.
Pretransplant  sinus  disease  assessment  by  CT  scans  has
ecome  standard  practice  in  majority  of  transplant  cen-
ers,  however,  only  limited  data  exist3,7--9 on  the  impact  of
retransplant  sinus  disease  assessed  by  CT  scans  on  the  post-
ransplantation  morbidity  and  mortality  with  two  studies
imited  to  children.10,11 No  guidelines  concerning  treat-
ent  of  chronic  sinusitis  prior  to  allogeneic  bone  marrow
o
eransplantation  exist,  although  earlier  studies  advocated
ggressive  surgical  intervention.12
Therefore,  we  decided  to  review  the  data  on  sinus  dis-
ase  in  available  literature  in  relation  to  the  bone  marrow
ransplantation.
ata sources and review methods
e  have  performed  searches  of  PubMed,  EMBASE  and  Sci-
LO  database  using  key  words:  sinusitis,  sinus  disease,
ematopoietic  stem  cell  transplantation,  bone  marrow
ransplantation,  invasive  fungal  sinusitis  and  identiﬁed  25
tudies  assessing  sinusitis  in  bone  marrow  transplant  recip-
ents.  All  research  were  non-experimental  and  descriptive
ith  III  category  of  evidence.13
tudy population, type of stem cell
ransplantation
he  majority  of  the  reviewed  studies  were  performed  in  the
ate  1980’s  and  1990’s.  The  number  of  analyzed  patients
anged  between  31  and  955  (Table  1).  The  type  of  analysis
iffered  between  studies.  While  some  researchers  analyzed
he  entire  population  of  the  transplanted  patients,1,3,4,14--16r  patients  for  whom  CT  scans  were  available  and  the
xact  number  of  transplanted  patients  from  whom  they
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Table  1  Time,  type  of  analysis,  number  of  patients  undergoing  both  auto-  and  allo-HSCT,  diagnosis.
Reference  Time  and  type  of  analysis  No  of  patients
with  HSCT
No  of  patients  with  different
diagnoses
Type  of  HSCT
AML  ALL  CML  Other  Allo  Auto
Savage  et  al.2 Aug  1993--Dec  1995;
retrospective
NA  (44  pts.  with
sinusitis)
NA  AL-2 NA  41  1  44  0
Yee et  al.14 Aug  1989--Oct  1991;
retrospective
136  (178  BMTs)  NA  NA  NA  NA  NA  NA
Thompson et  al.15 Jan  1998--Jun  1999;
retrospective
100  19  7  15  59  100  --
Shibuya et  al.1 Aug  1987--Jul  1989;
retrospective
107  18  12  18  59  63  44
Billings et  al.10 Jan  1992--Dec  1997;
retrospective
51  (children) 20  9  NA  NA  35  19
Moeller et  al.7 Jul  2006--Oct  2009;
retrospective
71  24  9  6  32  71  --
Ortiz et  al.8 2003--2004;  prospective  31  NA  NA  NA  NA  28  3
Won et  al.3 1996--2003;  retrospective  252  73  20  37  122  128  124
Fulmer et  al.9 Jan  2003--Jun  2009;
retrospective
228  79  9  11  140  194  43
Johnson et  al.16 Apr  1983--Jul  1992;
retrospective;  only  fungal
sinusitis  analyzed
955  NA  NA  NA  NA  NA  NA
Bento et  al.4 1996--2011;  retrospective  95  12  8  45  28  81  13
Sekine et  al.6 Sep  2005--Sep  2007;
retrospective
85  (children  and
adults)
NA  NA  NA  NA  NA  NA
Arulrajah et  al.17 2002--2004;  retrospective  NA  (64  with
available  CT;
children)
NA  NA  NA  NA  52  12
Zamora et  al.11 2006--2010  100  24  13  3  60
Kasow et  al.25 Jan  2004--Dec  2005;
retrospective
184  (children;
187  BMTs)
NA  NA  10  NA  131  56
Dhong et  al.5 Jan  1995--Dec  1998;
retrospective
34  NA  NA  NA  NA  NA  NA
; CML
mucopurulent  discharge  primarily  from  middle  meatus,
edema,  mucosal  obstruction  primarily  in  middle  meatus)  or
radiological  changes  in  CT  scans  (mucosal  changes  within  the
osteomeatal  complex  and/or  sinuses)  (Fig.  1).AML, acute myeloid leukemia; ALL, acute lymphoblastic leukemia
have  been  selected  remains  unknown.2,17 Analyzed  groups
contained  both  allogeneic  and  autologous  hematopoietic
stem  cell  transplants  recipients.  Chronic  myelogenous
leukemia  constituted  from  3%  to  93%  of  diagnoses  of  the
transplanted  patients.1,2,4,9,11,14,15 Patients  transplanted  for
pediatric  oncology  indications  were  also  included  in  the
several  analyzed  studies  (chorioncarcinoma,  sarcoma,  and
neuroblastoma1;  neuroblastoma10;  neuroblastoma,  Ewing
sarcoma,  brain  tumors).11
Deﬁnition of sinusitis
At  present,  European  Position  Paper  on  Rhinosinusitis  and
Nasal  Polyps  (EPOS)  guidelines  are  used  for  the  diagnosis
of  sinusitis.18 In  order  to  diagnose  rhinosinusitis  accord-
ing  to  these  criteria  the  patient  must  present  at  least
two  symptoms.  One  of  them  should  be  either  nasal  block-
age/obstruction/congestion  and  nasal  discharge  (anterior  or
posterior  nasal  drip),  while  the  other  may  be:  facial  pain  or
pressure,  reduction  or  loss  of  smell.  The  clinical  symptoms
must  be  accompanied  by  endoscopic  changes  (nasal  polyps,
F
a
s
c, chronic myelogenous leukemia; NA, not available.igure  1  CT  scan  of  the  sinuses.  Polyposis  of  the  maxillary
nd ethmoid  sinuses  (white  arrows)  in  a  patient  after  previous
inus surgery,  who  underwent  allogeneic  hematopoietic  stem
ell transplantation  because  of  primary  myeloﬁbrosis.
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The  majority  of  reports  concerning  sinusitis  in
ematopoietic  stem  cell  transplant  recipients  have
een  published  before  EPOS  criteria  have  been  established.
herefore,  criteria  utilized  in  different  studies  will  be  dis-
ussed  in  detail.  It  must  also  be  kept  in  mind,  that  according
o  some  authors,19 sinusitis  may  have  a  truly  occult  course,
ith  only  persistent  fever  with  radiological  changes,  or  at
east  less  symptomatic  course  than  in  immunocompetent
ounterparts  as  shown  by  Arulrajah  et  al.,17 which  is  not  in
ine  with  the  currently  used  deﬁnition.
Savage  et  al.  deﬁned  sinusitis  as  the  presence  of  clini-
al  symptoms  in  combination  with  radiological  ﬁndings  such
s:  ﬂuid  level,  complete  sinus  opaciﬁcation,  mucosal  thick-
ning  >5  mm  in  two  or  more  sinuses.  Chronic  sinusitis  was
iagnosed  when  there  was  little  symptomatic/radiological
mprovement  or  if  symptoms  recurred  after  3  or  more  weeks
f  antimicrobial  therapy.2
Thompson  et  al.,  diagnosed  acute  sinusitis  in  the  pres-
nce  of  symptoms,  such  as  blockage  or  congestion,  nasal
ischarge,  hyposmia,  facial  pressure  or  pain.15
Shibuya  et  al.  deﬁned  sinusitis  as  clinical  symptoms  of
inusitis  (solely  fever  in  17  out  of  22  newly  diagnosed
atients)  with  accompanying  radiological  ﬁndings  (some-
imes  only  thickening  of  the  mucosa  on  the  plain  ﬁlm),1 while
on  et  al.  deﬁned  sinusitis  as  radiological  abnormalities  of
he  paranasal  sinuses  accompanied  by  symptom  or  symp-
oms,  such  as  postnasal  drip,  rhinorrhea,  nasal  obstruction,
ough,  fever,  or  headache.3
Computed  tomography  scans  were  analyzed  most  fre-
uently  using  a  modiﬁed  version  of  the  method  of  Lund
nd  Mackay.7,9--11,15,17 In  this  method20,21 the  left  and  right
thmoid,  maxillary,  frontal  and  sphenoid  sinuses  were  each
iven  a  score  from  0  to  2,  where  0  denoted  a  clear  sinus,  1  --
artial  opacity,  and  2  --  total  or  near  total  opacity,  secondary
ither  to  mucosal  thickening  or  ﬂuid  levels.  The  osteomeatal
omplexes  were  also  assigned  a  score  from  0  or  2,  denot-
ng  their  patency  or  occlusion.  There  are  no  clear  cutoffs
or  categorization  of  CT  sinus  disease,  e.g.  in  the  work  of
hompson  et  al.  patients  were  arbitrarily  designated  as  hav-
ng  no  (score  of  0),  minimal  (1--3),  moderate  (4--10)  or  severe
inus  disease  (11--20),15 while  in  the  study  of  Fulmer  et  al.
he  cutoffs  were  as  follows:  no  disease  (0),  mild  disease
1--6),  moderate  disease  (7--12)  and  severe  disease  (13--24).9
 different  approach  was  used  in  studies  concerning  pedi-
tric  population.  The  total  score  of  sinus  opaciﬁcation  was
ivided  by  the  total  number  of  developed  sinuses.  Based
n  this  result,  the  severity  of  sinusitis  on  CT  was  catego-
ized  into  4  groups:  0%  for  no  evidence  of  sinusitis,  less
han  25%  for  mild  sinusitis,  26%--50%  for  moderate  sinusitis,
nd  greater  than  50%  for  severe  sinusitis.11,17 In  a work  of
rulrajah  et  al.  using  the  Lund-Mackay  system,  a score  of
--3  was  applied  for  each  sinus,  with  0  for  no  opaciﬁcation,
 for  1--49%  opaciﬁcation,  2  for  50--99%  opaciﬁcation,  and
 for  total  opaciﬁcation,  while  the  osteomeatal  complexes
ere  assigned  a  score  of  0  and  2,  denoting  their  patency  or
cclusion  respectively.17 Other  grading  systems  were  used
ither  alone  or  in  combination  with  Lund  system  by  other
esearchers.  Sinusitis  usually  was  deﬁned  as  the  presence
f  an  air-ﬂuid  level,  total  to  near  total  opacity  of  a  sinus
r  just  mucosal  thickening  accompanied  by  clinical  signs  of
inusitis.1,11,15
i
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Interestingly,  CT  scan  is  nonspeciﬁc  in  patients  with  inva-
ive  fungal  rhinosinusitis  and  does  not  correlate  with  surgical
nd  pathological  ﬁndings.  It  may  lead  to  underestimation  of
he  disease  extent,  not  visualizing  the  extension  of  the  dis-
ase  beyond  the  borders  of  the  sinuses.  In  these  patients
opulation,  endoscopy  and  Magnetic  Resonance  Imaging
MRI)  offer  better  imaging  options.19,22
In  the  analyzed  studies  the  endoscopic  evaluation  of
inuses  did  not  belong  to  the  standard  methods  of  assessing
he  extent  of  sinus  disease.  Only  Moeller  et  al.  tried  to
ssess  its  usefulness  in  hematological  patients.7 Grading
f  sinus  disease  with  the  use  of  endoscopy  was  performed
ccording  the  algorithm  of  Lund  and  Kennedy,  which  includes
he  degree  of  polyposis,  edema,  scarring,  crusting  and  dis-
harge.  The  maximum  score  is  10  per  side.
he  incidence  of  sinusitis
he  incidence  of  sinusitis  in  adults  in  the  post-transplant
eriod  reached  5--44%,1,3--6 while  the  incidence  of  inva-
ive  fungal  sinusitis  in  the  cohort  of  HSCT  patients  ranged
etween  0.5%  and  1.7%.16,23 Savage  et  al.  established  the
robability  of  developing  sinusitis  within  2  years  after  HSCT
t  36.9%  (95%  CI  49--77).2
The  time  that  elapsed  before  sinusitis  onset,  differed  sig-
iﬁcantly  between  patients.  In  the  work  of  Savage  et  al.  it
anged  between  7  and  1340  days  (median  93  days),  with
lmost  70%  of  cases  occurring  already  during  the  ﬁrst  120
ays,  and  only  10%  after  more  than  a  year.2 These  results
ere  similar  to  data  of  Won  and  coworkers  where  median
ime  to  diagnosis  reached  4.1  months  (95%  CI  1.768--6.432)3
nd  to  the  results  of  Sekine  et  al.,  where  time  to  diagnosis
as  127  days  for  allogeneic  HSCT  and  76  days  for  autolo-
ous  HSCT,6 whereas  in  the  work  of  Shibuya  et  al.  it  ranged
etween  2  and  833  days.1 In  the  paper  of  Kennedy,  who  ana-
yzed  solely  patients  with  invasive  fungal  sinusitis,  symptoms
tarted  after  an  average  of  21  days,  after  HSCT,  while  diag-
osis  was  made  after  25  days.23 However,  it  must  be  kept
n  mind,  that  patients  with  symptoms  onset  after  day  +100
ere  not  included  into  this  analysis.  The  other  authors  did
ot  report  the  time  to  sinusitis  onset.
isk  factors  of  post-transplant  sinusitis
erlinger  et  al.  in  their  pioneer  study  analyzing  sinusitis
n  immunodeﬁcient  and  immunosuppressed  patients  have
ound  that  the  White  Blood  Cells  (WBC)  count  of  2.0  G/L
r  less  in  a  patient  with  sinus  disease  and  the  presence  of
ematologic  malignancy  was  a  very  poor  prognostic  factor.12
n  the  trials  addressing  strictly  hematologic  population  of
atients,  different  parameters  were  suggested  as  potential
isk  factors  of  developing  sinusitis  after  HSCT;  among  them
he  ones  analyzed  earlier  by  Berlinger  et  al.,  as  well  as
rimary  diagnosis,  disease  stage  (complete  remission  versus
ctive/refractory  disease),  absolute  neutrophil  count,
ow  IgG  concentration  in  blood,  acute  and  chronic  Graft
ersus  Host  Disease  (GvHD),  corticosteroid  use,  condition-
ng  regimen  and  especially  Total  Body  Irradiation  (TBI)
se,  bone  marrow  source  --  related  vs.  unrelated  donor,
ytomegalovirus  (CMV)  status,  concomitant  pneumonia,
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Figure  2  CT  scan  of  the  sinuses.  A  polyp  obstructing
osteomeatal  complex  (white  arrow)  in  a  patient  diagnosed  with
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Sinusitis  in  bone  marrow  transplant  recipients  
history  of  previous  sinus  disease,  tobacco  use,  asthma  and
other  allergies.
The  impact  of  type  of  transplant  on  sinusitis  development
differed  among  studies.  Although  sinus  abnormalities  were
signiﬁcantly  higher  among  allografted  than  autografted
hematopoietic  stem  cell  transplant  recipients  (p  =  0.027),1
no  clear  association  could  be  made  between  the  type  of
transplant  and  sinusitis.  While  there  was  a  tendency  for
more  frequent  sinusitis  occurrence  in  the  alloHSCT  setting
in  comparison  to  autologous  one  in  the  study  of  Won  et  al.
(p  =  0.06),3 no  such  phenomenon  could  be  observed  in  the
study  of  Bento  et  al.4
In  the  group  of  allografted  patients  only  higher  TBI  dose
(1440  or  1320  cGy  vs.  1200  cGy)  was  statistically  signiﬁcant
for  developing  sinusitis  (p  =  0.023),  while  matched  unrelated
donor  transplant  or  donor  CMV  seropositivity  reached  only  a
borderline  signiﬁcance  (p  =  0.08  and  0.11  respectively).2
The  analysis  of  the  impact  of  GvHD  on  the  sinusitis  occur-
rence  yielded  inconsistent  results.  According  to  Thompson
et  al.,  Ortiz  et  al.  and  Bento  et  al.  it  put  patients  at  higher
risk  of  developing  sinusitis  in  the  post-transplant  period
(RR  =  4.3;  95%  CI  1.7--11;  p  =  0.002),4,15,24 whereas  in  the
work  of  Shibuya  it  did  not  have  any  impact  on  morbidity.1 In
the  study  of  Won  GvHD  did  not  inﬂuence  the  occurrence  of
sinusitis  in  the  entire  group  of  transplanted  patients,  how-
ever  when  asymptomatic  patients  with  solely  radiological
abnormalities  prior  to  transplantation  were  analyzed  sepa-
rately,  both  acute  and  chronic  GvHD  put  these  patients  at
higher  risk  of  developing  sinusitis  (p  =  0.005  and  p  =  0.042
respectively).3
Similarly  to  GvHD,  analysis  of  the  impact  of  pretrans-
plant  sinus  disease  (symptoms  at  time  of  transplant,  history
of  sinusitis,  and  signiﬁcant  disease  on  screening  CT)  on
post-transplant  sinusitis  led  to  inconsistent  conclusions.
While  according  to  some  authors  it  did  inﬂuence  post-HSCT
morbidity,3,9--11 according  to  others  it  did  not.7,15 However,
in  the  work  of  Thompson  et  al.  all  patients  with  abnor-
mal  radiographic  ﬁndings  during  screening  and  symptoms  of
sinusitis,  as  well  as  majority  of  patients  with  abnormal  radio-
graphic  ﬁndings  were  treated  prior  to  transplantation.15
Prolonged,  profound  neutropenia  was  found  in  all
patients  experiencing  invasive  fungal  sinusitis  in  the  study  of
Johnson  et  al.,16 however  no  formal  risk  factor  analysis  was
performed  by  the  authors.  On  the  other  hand  in  the  study
of  Sekine  et  al.,  lower  neutrophil  count  was  associated  with
lower  Lund-Mackay  score  at  the  time  of  rhinosinusitis  diag-
nosis,  probably  indicating  that  patients  lacking  neutrophils
are  not  able  to  mount  an  effective  inﬂammatory  response
capable  of  inducing  signiﬁcant  tomographic  abnormalities.6
It  is  worth  mentioning  that  there  was  no  increased  risk
of  developing  sinusitis  post  HSCT  for  patients  with  high  risk
of  disease  relapse.
Value of sinonasal evaluation including
computed tomography, endoscopy and
microbiological ﬁndings preceding
hematopoietic  stem cell transplantationSinonasal  evaluation  was  performed  in  the  majority  of  cases
with  the  use  of  pretransplant  CT  (Fig.  2).  In  the  earlier  stud-
ies  sinus  X-ray  series  were  taken  as  a  screening  test.5 Apart
s
w
i
scute myeloid  leukemia,  qualiﬁed  for  allogeneic  hematopoietic
tem  cell  transplantation.
rom  radiographic  methods,  also  endoscopic  and  microbi-
logic  ﬁndings  were  included  in  the  assessment  of  sinus
isease.
Moeller  et  al.  were  not  able  to  show  any  relationship
etween  the  result  of  pre-HSCT  sinonasal  evaluation  and
ost-HSCT  outcome.7 However,  screening  CT  was  performed
nly  for  19  out  of  71  analyzed  patients.  The  average  Lund
core  prior  HSCT  was  2.2  ±  3.7,  with  79%  patients  having
core  of  no  more  than  3.  Mean  endoscopic  grading,  per-
ormed  for  all  analyzed  patients,  reached  0.6  ±  1.6  (77%  pts.
-  score  0;  94%  pts.  --  score  ≤2).  Only  4  out  of  71  patients
6%),  all  showing  symptoms,  were  diagnosed  with  chronic
hinosinusitis,  with  3  of  them  requiring  medical  interven-
ion.  Interestingly,  3  out  of  these  4  patients  had  endoscopic
core  of  0.  The  authors  therefore  concluded  that  although
ndoscopy  seems  useful  in  evaluation  of  sinuses  in  general,  it
s  not  a  good  screening  tool  in  patients  qualiﬁed  for  alloHSCT.
n  the  post-HSCT  period  only  2  patients  developed  acute
hinosinusitis.  There  was  no  correlation  with  pretransplant
ndings  in  this  group.  The  authors  were  also  not  able  to
nd  any  correlation  between  cultures  from  middle  meatus
nd  subsequent  sinusitis,  as  only  one  out  of  33  patients  with
ultures  developed  rhinosinusitis.
Billings  et  al.  found,  analyzing  the  extend  of  sinus  disease
rior  to  transplantation  with  the  use  of  screening  CT,  that
8%  of  patients  had  no  sinus  disease,  25.9%  had  mild  disease,
.3%  moderate  disease  and  16.7%  severe  disease.  Unlike
ther  authors,  they  found  that  severity  of  radiographic  sinus
isease  on  pre-HSCT  CT  scans  correlated  with  clinical  and
adiographic  sinusitis  later  in  the  post-HSCT  course,  and  was
ssociated  with  a  trend  toward  decreased  survival.  Two-
hirds  of  patients  with  severe  sinus  disease  on  pre-HSCT
T  scans  experienced  clinical  sinusitis  after  transplantation,
hile  only  21.4%  of  patients  with  mild  disease.  As  much  as
9.3%  of  patients  with  sinus  abnormalities  on  pre-HSCT  CT
cans  had  clinical  sinusitis  during  their  post-transplantation
ourse,  compared  to  23.1%  of  those  with  normal  CT  scans.10
n  the  most  recent  study  of  Zamora  et  al.,  who  analyzed
lso  the  pediatric  population,  14%  of  patients  with  normal
creening  CT  developed  post-transplant  sinusitis,  compared
ith  23%  with  radiographic  abnormalities  and  22%  with  clin-
cal  sinusitis  alone.  The  differences  however  did  not  reach
tatistical  signiﬁcance.  Subgroup  analysis  of  patients  with
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bnormal  pre-HSCT  scans  stratiﬁed  by  the  Lund-Mackay
core  (mild  vs.  moderate/severe)  was  also  not  found  to
orrelate  with  development  of  clinical  sinusitis  after  HSCT
p  = 0.58).  The  sensitivity  of  radiographic  ﬁndings,  analyzed
ither  alone  or  in  combination,  was  low  or  ranged  between
9%  and  56%,  while  the  speciﬁcity  ranged  between  71%  and
7%.  The  positive  predictive  value  of  having  acute  clinical
inusitis  for  a  given  radiographic  abnormality  was  highest  for
ombined  CT  ﬁndings  (67%),  total  sinus  opaciﬁcation  (56%),
rothy  secretions  (53%),  and  ﬂuid  levels  (47%)  and  lowest
or  mucosal  thickening  alone  (13%).  In  this  study  the  Lund-
ackay  score  change  of  10  or  greater  from  baseline  was
ssociated  with  a  2.8  fold  increased  likelihood  of  having  clin-
cal  sinusitis  (p  <  0.001;  95%  CI  1.32--5.81).11 Kasow  et  al.
n  their  study  concerning  children  showed,  that  as  much
s  67.2%  of  alloHSCT  and  55.4%  of  autoHSCT  patients  had
bnormal  sinus  ﬁndings,  which  were  unrelated  to  the  under-
ying  disease  process  prior  to  transplantation.  Unfortunately
he  authors  did  not  report  on  the  severity  of  these  patho-
ogical  ﬁndings,  nor  on  their  impact  on  the  post-transplant
utcome.25 In  the  study  of  Fulmer  et  al.  mean  Lund  score
rior  to  transplantation  was  3.03,  and  reached  7.91  after
he  procedure.  However  only  patients  suspected  of  rhi-
osinusitis  had  a  CT  performed  after  HSCT.  Nevertheless
hen  these  patients  were  analyzed  separately,  there  was
 signiﬁcant  increase  in  Lund  score  after  HSCT.  Additionally
hese  patients  showed  higher  rate  of  sinus  changes  on  pre-
SCT  CT  scans.  The  authors  therefore  concluded,  that  the
re-HSCT  CT  scan  correlated  signiﬁcantly  to  the  post-HSCT
T  scans.9
Won  et  al.  found,  that  96  patients  (38.1%)  out  of  252
nalyzed,  did  present  radiological  abnormalities  alone  prior
o  transplantation,  which  translated  into  sinusitis  in  15
f  them  (15.6%)  in  the  post-transplant  period.  Among  23
atients  (9.1%)  diagnosed  with  sinusitis  before  transplanta-
ion  8  had  recurrent  disease  (34.8%).  The  magnitude  of  the
adiological  abnormalities  is  not  reported  in  this  study;  fur-
hermore  allo-  and  auto-transplanted  patients  are  reported
ogether.3
ndications  for  the  treatment  of  sinusitis
here  are  no  clear  guidelines  for  the  optimal  management
f  patients  diagnosed  to  have  sinusitis  during  pretransplant
ork  up,  as  well  as  in  the  post-transplant  period,  especially
ith  respect  to  sinus  surgery.
Berlinger  et  al.  analyzing  sinusitis  in  immunodeﬁcient  and
mmunosuppressed  patients  have  found  that  the  WBC  count
f  2.0  G/L  or  less  in  a  patient  with  sinus  disease  and  the  pres-
nce  of  hematologic  malignancy  is  a  very  poor  prognostic
ign  and  mandates  surgical  intervention.12 Similar  recom-
endations  were  made  by  Shaw  et  al.  who  advocated  sinus
urgery  prior  to  immunosuppression.26
Other  authors  recommended  a  conservative  medical
pproach  to  sinusitis  in  the  population  of  hematopoietic
tem  cell  transplant  recipients,1,27 unless  the  etiologic
actor  is  aspergillus,  mucormycosis,  phycomycetes,  pseu-
omonas,  which  are  associated  with  high  mortality
ate,1,16,22 especially  if  sphenoid  sinus  is  involved.16
Such  an  attitude  may  be  supported  by  the  results  of
terman’s  analysis.  He  analyzed  the  results  of  sinus  surgery
f
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n  allogeneic  hematopoietic  stem  cell  transplant  recipi-
nts,  and  was  not  able  to  show  any  survival  beneﬁt  in
atients  treated  according  to  aggressive  surgical  approach
.e.  antral  lavage  or  ethmoidectomy.28 On  the  contrary,
atients  treated  surgically  had  mortality  rate  of  57%,  which
as  lowered  to  0%  when  endoscopy  for  possible  diagnosis  of
ungal  infection  was  introduced.  Similarly  Kennedy  et  al.,
nalyzing  solely  patients  with  invasive  fungal  sinusitis  were
ot  able  to  demonstrate  the  advantage  of  more  extensive
urgery  in  comparison  to  limited  drainage  procedures  or
imited  debridement.23 Endoscopic  sinusectomy  was  also  a
aluable  option  in  patients  suffering  from  GvHD,  having  a
reater  need  for  surgical  treatment  (p  <  0.001).4
Shibuya  et  al.  advocated  that  if  the  sinus  disease  is
efractory  to  medical  therapy,  sinus  surgery  may  be  a  rea-
onable  approach.1
onclusions
aranasal  sinusitis,  as  shown  in  the  review,  constitutes  a
ajor  problem  for  both  hematologists  treating  the  patients
s  well  as  otorhinolaryngologists  consulting  on  subjects  sus-
ected  of  sinusitis  or  exhibiting  abnormal  changes  on  CT
cans.
Results  from  quoted  studies  frequently  yielded  inconsis-
ent  results.  Furthermore  --  many  analyses  covered  both
uto-  and  allogeneic  hematopoietic  stem  cell  transplan-
ations.  As  shown  in  the  risk  factor  analysis,  patients
ndergoing  allogeneic  SCT  are  probably  a totally  different
atients’  group  than  patients  undergoing  only  autologous
CT.  Therefore  there  is  a  need  for  separate  analysis  of  these
roups  of  patients.  In  the  evaluated  studies  the  signiﬁcant
roup  of  the  transplanted  patients  suffered  from  chronic
yelogenous  leukemia  (CML),  chronic  phase.  This  is  not  a
tandard  indication  for  transplantation  currently,  apart  from
are  situations,  when  there  is  resistance  for  tyrosine  kinase
nhibitors  (e.g.  T315I  mutation).  This  patients’  population
iffers  from  the  ‘‘standard’’  transplanted  population  in  the
isease  duration,  number  of  previous  chemotherapy  cycles
usually  none),  time  spent  in  the  hospital,  previous  time  with
eutropenia  and  hence  the  possibility  of  microbial  coloniza-
ion,  especially  with  multi-drug  resistant  species.
Nevertheless,  some  recommendations  for  good  practice
ased  upon  the  current  knowledge  could  be  made.  First,
lthough  data  is  inconsistent,  it  seems  advisable  to  screen
ll  patients  undergoing  allogeneic  hematopoietic  stem  cell
ransplantation  with  CT  prior  to  procedure.  In  selected
ases,  endoscopy  of  the  sinuses  should  also  be  performed.
econd,  patients  with  symptoms  of  sinusitis  should  be
reated  before  HSCT,  preferably  with  conservative  medi-
al  approach.  Third,  patients  who  have  undergone  HSCT
hould  be  monitored  closely  for  sinusitis,  especially  in  the
arly  period  after  transplantation.  We  would  also  like  to
tress,  that  according  to  some  authors,19 sinusitis  may  have
n  occult  course,  with  only  persistent  fever,  which  is  not
n  line  with  the  currently  used  deﬁnition  or  be  less  symp-
17or  patients  to  assume  that  they  have  sinusitis  and  intro-
uce  treatment  than  neglect  this  possibility  and  allow  for
oth  local  and  generalized  spread  of  infection  which  may  be
atal.
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